• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Screening
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Higher Green Tea and Coffee Intake May Reduce Mortality Risk in Patients with T2D

Article

A new study of Japanese adults with type 2 diabetes found dual consumption of green tea and coffee reduced mortality risk by >60%.

Girl holding white cup in hands. White mug in woman's hands.

©maddyz

Japanese adults with type 2 diabetes (T2D) who consumed more coffee and green tea were less likely to die of any cause during 5 years of follow-up, according to a new study published in BMJ Open Diabetes Research & Care.

“In this prospective study, we found that higher green tea and coffee consumption was significantly associated with decreased all-cause mortality in patients with type 2 diabetes,” wrote authors led by Yuji Komorita, MD, PhD, Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. “Further, the combination of higher green tea and coffee consumption significantly reduced all-cause mortality risk by 63%.”

Through antioxidant, anti-inflammatory, or antibacterial properties, the authors write, higher green tea consumption has been reported to confer health benefits such as diabetes prevention. Higher green tea or coffee intake has been reported to reduce all-cause mortality in the general population, but little is known on the association between green tea and coffee consumption and mortality in patients with diabetes, according to the study.

For this reason, Komorita and colleagues analyzed data from 4923 adults with T2D (2790 men; mean age 66 years) who were followed prospectively for a median of 5.3 years. Green tea and coffee consumption were evaluated using self-administrated questionnaires; 309 participants died during follow-up.

Results showed that the multivariable-adjusted hazard ratio [HR] for mortality was significantly lower in participants who consumed ≥4 cups/day of green tea vs those who reported drinking none (HR, 0.60; 95% CI, 0.42-0.85). In the coffee group, the multivariable-adjusted HR for all-cause mortality was significantly lower among participants who drank ≥2 cups/day vs those who did not consume coffee (HR, 0.59; 95% CI, 0.42-0.82).

The greatest reduction in all-cause mortality was observed among participants reporting drinking both green tea and coffee.

Compared to participants who drank neither beverage, those who consumed 2-3 cups/day of green tea with ≥2 cups/day of coffee/day were half as likely to die of any cause during follow-up (HR, 0.49; 95% CI, 0.24-0.99), suggesting an additive benefit of consuming both beverages.

Participants who consumed ≥4 cups/day of green tea with 1 cup/day of coffee were 63% less likely to die during follow-up vs those who did not drink either beverage (HR, 0.37; 95% CI, 0.18-0.77).

Of note, researchers cautioned that because it was an observational study, they could not conclude that green tea and coffee intake reduces death – only that consuming them is associated with lower risk.

“Our results suggest that consuming green tea and coffee may have beneficial effects on the longevity of Japanese people with type 2 diabetes,” concluded authors.


Recent Videos
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
Document COVID Sequelae and Primary Care: An Interview with Samoon Ahmad, MD
© 2024 MJH Life Sciences

All rights reserved.